Markets
Alerts
F&O
MF
Reports
Screeners
Subscribe
Superstars
Portfolio
Watchlist
Insider Trades
Results
Data Downloader
Events Calendar
What's New
Explore
FAQs
Widgets
More
Search stocks
IND
USA
IND
IND
×
Close
IND
USA
Stocks
Futures & Options
Mutual Funds
News
Fundamentals
Reports
Corporate Actions
Alerts
Shareholding
Stocks
Concord Drugs Ltd.
Swot
Concord Drugs Ltd. SWOT Analysis: Strengths, Weakness, Opportunity, and Threats
Concord Drugs Ltd. has 25 Strengths, 6 Weaknesses, 0 Opportunities and 0 Threats. The SWOT product gives you a quick x-ray of a stock's outlook and potential
Add SWOT widget to your site/app
Strengths
(25)
Weakness
(6)
Opportunity
(0)
Threats
(0)
Others
(6)
30 Day SMA crossing over 200 Day SMA, and current price greater than open
Companies with 10% increase in share price over three months, with rising net profit growth
Strong Momentum: Price above short, medium and long term moving averages
Consistent Highest Return Stocks over Five Years
Relative Outperformance versus Industry over 1 Month
Relative Outperformance versus Industry over 1 Year
Companies with high TTM EPS Growth
Weekly Strategy: High Momentum Score Stocks (subscription)
PEG lower than Industry PEG
High Momentum Scores (Technical Scores greater than 50)
Relative Outperformance versus Industry over 1 Week
Relative Outperformance versus Industry over 1 Month
Companies with rising net profit margins - quarterly as well as TTM basis
Overbought by Money Flow Index (MFI)
Growth in Net Profit with increasing Profit Margin (QoQ)
Companies with Zero Promoter Pledge
Negative to Positive growth in Sales and Profit with Strong Price momentum
Highest Recovery from 52 Week Low
RSI indicating price strength
High Volume, High Gain
Biggest Price Gainers from Open
Top Gainers
High Volume, High Gain
Volume Shockers
Stocks Outperforming their Industry Price Change in the Quarter
PE higher than Industry PE
High PE (PE > 40)
Inefficient use of shareholder funds - ROE declining in the last 2 years
Inefficient use of assets to generate profits - ROA declining in the last 2 years
Declining Net Cash Flow : Companies not able to generate net cash
Annual net profit declining for last 2 years
Strong Performers - High DVM Stocks
Bullish or Bearish Candlestick Strength - Indices
Trendlynes high return technically strong value stocks (subscription)
Average Affordability - Stocks with Medium Trendlyne Valuation Score versus Benchmarks
Average Financial Performers - Stocks with Medium Trendlyne Durability Score versus Benchmarks
Decline in Quarterly Net Profit with falling Profit Margin (YoY)
